Past Event
Date
March 15-20, 2022
Location
Barcelona, Spain & Virtual
AD/PD (Alzheimer/Parkinson’s)
2022 Advances in Science & Therapy
Sessions
March 20th 9:00 am CET
Quantitative Systems Pharmacology Amyloid Platform: Multiscale Computational Modeling of ABETA Biology and Its Interaction with Aducanumab Pharmacology
Hugo Geerts, Head QSP Neurosciences, Certara; Mike Walker, Principal Scientist, Certara; Rachel Rose, Principal Scientist QSP, Certara; Silke Bergeler, Research Scientist, Certara; E. Schuck, Eisai; A. Akihiko Koyama, Eisai; S. Yasuda, Eisai; L. Reyderman, Eisai; C. Swanson, Eisai |
March 20th 9:05 am CET
1400 - ABETA and Other Targeting Therapies in AD (ID 95)
A. Cabal, Eisai; Hugo Geerts, Head QSP Neuroscience, Certara; Mike Walker, Principal Scientist, Certara; Rachel Rose, Principal Scientist, Certara; Silke Bergeler, Research Scientist, Certara; E. Schuck, Eisai; A. Akihiko Koyama, Eisai; S. Yasuda, Eisai; L. Reyderman, Eisai; C. Swanson, Eisai |
March 16th 7:00 am CET
Poster ID OO011 - The Impact of TAU, Comedications and Genotypes on Cognitive Outcome of Aducanumab: A Quantitative Systems Pharmacology Study
Hugo Geerts, Head QSP Neuroscience, Certara; Mike Walker, Principal Scientist, Certara; Silke Bergeler, Research Scientist, Certara; Piet van der Graaf, SVP QSP, Certara |
Poster - QSP model describing the dynamics of microglial phenotypes: Effect of treatments targeting microglia
Uddipan Sarma, Scientist, Certara; Douglas Chung, Scientist, Certara; Julie Stone, Merck; Peter Bloomingdale, Merck; Hugo Geerts, Head QSP Neuroscience,, Certara; Piet van der Graaf, SVP QSP,Certara; Viji Chelliah, Principal Scientist, Certara |
On-Demand
Poster - QSP model of neuroinflammation: Effect of TREM2 stimulation on microglial activation and function in the context of Alzheimer’s disease
Viji Chelliah, Principal Scientist, Certara; Uddipan Sarma, Scientist, Certara; Douglas Chung, Scientist, Certara; Hugo Geerts, Head QSP Neuroscience, Certara; Piet H van der Graaf, SVP QSP, Certara; Cheryl Leyns, Merck; Matthew Kennedy, Merck; Julie Stone, Merck; Peter Bloomingdale, Merck |
On Demand
